It is being evaluated in Phase 3 trials, the first of which (SYNCHRONIZE-1, in obesity) reported positive topline results in 2026
Open-Chain Precursor 1980 [Nle, D-Phe]--MSH (NDP-MSH) the linear precursor to Melanotan II Sawyer, Sanfilippo, Hruby, Engel, Heward, Burnett, and Hadley reported 26 -MSH adenylate cyclase potency for NDP-MSH
For instance, studies have observed a significant reduction of wrinkle volume, with some research indicating reductions of over 30% compared to other active compounds and over 50% compared to control serum
It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any medical condition or disease
Bogatyrev, S